[Form 4] Y-mAbs Therapeutics, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Wedell-Wedellsborg Johan
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 33,450 | $0.00 | -- |
| Grant/Award | Common Stock | 25,080 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 33,450 shares (Direct);
Common Stock — 30,905 shares (Direct);
Common Stock — 4,559,233 shares (Indirect, By WG Biotech ApS)
Footnotes (1)
- Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. The RSUs vest in full on the earlier of the first anniversary of the date of grant or the date immediately preceding the date of the Issuer's annual meeting of stockholders held in 2026, subject to the Reporting Person's continued service to the Issuer on the vesting date. Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. Stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. The stock options vest in equal monthly installments until the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer on each vesting date, and are exercisable immediately upon vesting.
